Header cover image

Pharmaceuticals & Biotech Top Rated Asian Stocks

Results

16

3 new

Financially healthy companies listed on Asian stock exchanges with an impressive track record.

16 companies

Laurus Labs

Market Cap: ₹998.7b

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.

LAURUSLABS

₹1,851.70

7D

1.2%

1Y

115.4%

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$60.0b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

2315

HK$70.25

7D

26.5%

1Y

186.0%

Anthem Biosciences

Market Cap: ₹494.7b

Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.

ANTHEM

₹874.90

7D

6.0%

1Y

6.1%

Emcure Pharmaceuticals

Market Cap: ₹381.0b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

EMCURE

₹2,009.60

7D

3.8%

1Y

38.1%

Sai Life Sciences

Market Cap: ₹310.5b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

New

SAILIFE

₹1,451.20

7D

2.7%

1Y

63.5%

Neuland Laboratories

Market Cap: ₹288.7b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

524558

₹23,222.15

7D

8.0%

1Y

75.1%

Rubicon Research

Market Cap: ₹273.7b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

RUBICON

₹1,620.70

7D

5.7%

1Y

n/a

Acutaas Chemicals

Market Cap: ₹258.2b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

ACUTAAS

₹3,110.60

7D

-4.6%

1Y

139.3%

Granules India

Market Cap: ₹214.4b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.

532482

₹857.45

7D

2.3%

1Y

86.8%

Aether Industries

Market Cap: ₹214.0b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

AETHER

₹1,580.10

7D

-0.3%

1Y

113.1%

Jinyu Bio-technology

Market Cap: CN¥15.0b

Engages in the research and development, production, and sale of veterinary biological products in China and internationally.

New

600201

CN¥13.64

7D

4.2%

1Y

62.0%

Inner Mongolia Furui Medical Science

Market Cap: CN¥11.8b

Inner Mongolia Furui Medical Science Co., Ltd.

300049

CN¥46.38

7D

7.7%

1Y

-4.5%

Shilpa Medicare

Market Cap: ₹157.3b

Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.

530549

₹807.40

7D

9.1%

1Y

78.1%

Viyash Scientific

Market Cap: ₹114.8b

Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.

512529

₹266.45

7D

-2.4%

1Y

51.9%

Strides Pharma Science

Market Cap: ₹91.6b

A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.

STAR

₹989.20

7D

-0.8%

1Y

10.5%

Sakar Healthcare

Market Cap: ₹20.8b

Research, develops, manufactures, and sells pharmaceutical products in India.

New

SAKAR

₹918.30

7D

-0.2%

1Y

182.0%